Recommendations and Practices to Optimize Stroke Therapy Developing Effective Translational Research Programs

被引：22

作者：

Lapchak, Paul A. ^{[1
]}

机构：

[1] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA

来源：

STROKE | 2013年 / 44卷 / 03期

关键词：

brain; clinical trial; hemorrhage; NIHSS; RIGOR; STAIR; stroke; translational; TISSUE-PLASMINOGEN ACTIVATOR; ISCHEMIC-STROKE; ANIMAL-MODELS; SUBTYPES; NXY-059; THROMBOLYSIS; RELEVANT; EFFICACY;

D O I：

10.1161/STROKEAHA.112.680439

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：841 / 843

页数：3

共 33 条

[1] Effects of NXY-059 in experimental stroke: an individual animal meta-analysis [J].

Bath, P. M. W. ;

Gray, L. J. ;

Bath, A. J. G. ;

Buchan, A. ;

Miyata, T. ;

Green, A. R. .

BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (07) :1157-1171

[2] A Model of Cost-effectiveness of Tissue Plasminogen Activator in Patient Subgroups 3 to 4.5 Hours After Onset of Acute Ischemic Stroke [J].

Boudreau, Denise M. ;

Guzauskas, Greg ;

Villa, Kathleen F. ;

Fagan, Susan C. ;

Veenstra, David L. .

ANNALS OF EMERGENCY MEDICINE, 2013, 61 (01) :46-55

[3]

Casals JB, 2011, COMPARATIVE MED, V61, P305

[4] Nonhuman Primate Models of Stroke for Translational Neuroprotection Research [J].

Cook, Douglas J. ;

Tymianski, Michael .

NEUROTHERAPEUTICS, 2012, 9 (02) :371-379

[5] International, multicenter randomized preclinical trials in translational stroke research: It's time to act [J].

Dirnagl, Ulrich ;

Fisher, Marc .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2012, 32 (06) :933-935

[6] Fighting publication bias: introducing the Negative Results section [J].

Dirnagl, Ulrich ;

Lauritzen, Martin .

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2010, 30 (07) :1263-1264

[7] The 2007 feinberg lecture - A new road map for neuroprotection [J].

Donnan, Geoffrey A. .

STROKE, 2008, 39 (01) :242-248

[8] Erythropoietin therapy for acute stroke is both safe and beneficial [J].

Ehrenreich, H ;

Hasselblatt, M ;

Dembowski, C ;

Cepek, L ;

Lewczuk, P ;

Stiefel, M ;

Rustenbeck, HH ;

Breiter, N ;

Jacob, S ;

Knerlich, F ;

Bohn, M ;

Poser, W ;

Rüther, E ;

Kochen, M ;

Gefeller, O ;

Gleiter, C ;

Wessel, TC ;

De Ryck, M ;

Itri, L ;

Prange, H ;

Cerami, A ;

Brines, M ;

Sirén, AL .

MOLECULAR MEDICINE, 2002, 8 (08) :495-505

[9] Recombinant Human Erythropoietin in the Treatment of Acute Ischemic Stroke [J].

Ehrenreich, Hannelore ;

Weissenborn, Karin ;

Prange, Hilmar ;

Schneider, Dietmar ;

Weimar, Christian ;

Wartenberg, Katja ;

Schellinger, Peter D. ;

Bohn, Matthias ;

Becker, Harald ;

Wegrzyn, Martin ;

Jaehnig, Peter ;

Herrmann, Manfred ;

Knauth, Michael ;

Baehr, Mathias ;

Heide, Wolfgang ;

Wagner, Armin ;

Schwab, Stefan ;

Reichmann, Heinz ;

Schwendemann, Guenther ;

Dengler, Reinhard ;

Kastrup, Andreas ;

Bartels, Claudia .

STROKE, 2009, 40 (12) :E647-E656

[10] Trends in Thrombolytic Use for Ischemic Stroke in the United States [J].

Fang, Margaret C. ;

Cutler, David M. ;

Rosen, Allison B. .

JOURNAL OF HOSPITAL MEDICINE, 2010, 5 (07) :406-409

← 1 2 3 4 →